Oncology Development

For a leading cancer research charity, Alacrita is providing project management and drug development expertise to shepherd two preclinical programmes into Phase I/II clinical trials. Specific duties include overseeing the formal preclinical development programme, submission of IND and execution of a Phase I/II clinical trial for two of the charity’s targeted therapy compounds. Alacrita is responsible for:

  • identifying and negotiating contracts with appropriate CROs
  • managing the CRO relationships
  • identifing and overcoming issues as they arise
  • ensuring regulatory compliance
  • liaising with ethics committees where necessary
  • monitoring and ensuring GMP compliance
  • providing regular progress reports to the client

Vaccine Product Development

Alacrita is providing expert advice to the HIV Vaccines Consortium, including extensive advice concerning the procurement of specific vaccine services from third party suppliers. In particular, the supply chains for a number of candidate vaccine constructs were assessed for feasibility, cost and fit within the portfolio of planned trials.

Business Development

Alacrita is providing hands-on support to a listed North American company on the identification, assessment and in-licensing of early stage oncology assets.  Alacrita leveraged its industry network and contacts to identify a number of high quality opportunities that had not yet been analysed by the clients’s in house business development team. Alacrita is working closely with the client’s scientific staff to screen and assess opportunities prior to entering heads of terms, and is providing advice on structuring heads of terms, due diligence and licence negotiations.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch